FineHeart inks Series B
FineHeart S.A, a preclinical medical device company, has secured 15 million euros in Series B funding.
FineHeart S.A, a preclinical medical device company, has secured 15 million euros in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination